Cancer Treatment News and Research

RSS

High intensity focused ultrasound to treat prostate cancer shows initial success

A new tumor treatment that involves heating it with highly focused ultrasound, may mean men with prostate tumors can be treated without an overnight stay in hospital and avoiding the distressing side effects associated with current therapies.

17 Apr 2012

More than one third of patients with invasive cancer are undertreated for their pain

More than one third of patients with invasive cancer are undertreated for their pain, with minorities twice as likely to not receive analgesics, according to research from The University of Texas MD Anderson Cancer Center.

17 Apr 2012

Physical activity reduces depression, enhances QOL during treatment for breast cancer

Women undergoing treatment for breast cancer might fight off distressing side effects and improve psychological well-being by staying off the couch. According to the University of Miami (UM) study, women who are physically active during treatment have less depression and an enhanced quality of life and report less debilitating fatigue.

16 Apr 2012

Longer looks: Diagnosing autism in minutes; Finding new uses for old drugs; Cancer war victories

Autism is an extremely complex diagnosis. Parental insight, physician observations and hours of data can factor into determining whether a child actually has the condition or is just a little on the quirky side. Now a Harvard researcher, Dennis P. Wall, has published research about a Web-based tool he developed that promises to diagnose autism in minutes, not hours -;

12 Apr 2012

New image-guided radiotherapy system at DMC Huron Valley-Sinai Hospital

A new image-guided radiotherapy system will be dedicated on Thurs., April 19, 2012 at DMC Huron Valley-Sinai Hospital. The TrueBeam system treats cancer more effectively through highly precise targeting of lung, breast, prostate, and head and neck tumors.

12 Apr 2012

Majority of Michigan oncology practices follow treatment guidelines for common cancers

A majority of Michigan oncology practices participating in a statewide consortium followed treatment guidelines for common cancers, but had gaps in managing symptoms and end-of-life care, according to a new study.

11 Apr 2012

New supplement outlines prospective surveillance model for breast cancer

A new supplement in the journal Cancer outlines an innovative model to address a wide range of physical issues faced by women with breast cancer and offers hope for improved function and full participation in life activities for patients through rehabilitation and exercise.

11 Apr 2012

Peter Mac doctor receives grant to fight prostate cancer

The Victorian Minister for Health, the Hon David Davis, with the Richard Pratt Fellowships in Prostate Cancer Foundation and the Carlton Football Club, today announced Dr Helen Pearson as the 2012 recipient of the Richard Pratt Fellowship in Prostate Cancer Research.

10 Apr 2012

Spider venom studied as treatment for breast cancer

James Cook University Professor Norelle Daly has received a $205,000 research grant from the National Breast Cancer Foundation to analyze whether the venom of tarantulas and funnel web spiders can kill breast cancer cells.

10 Apr 2012

High cancer treatment costs in the US – are they worth it? Study explores

Healthcare in the United States is costlier than care in other countries. A new analysis suggests that the cost may be worth it at least when it comes to cancer care. Americans may pay more for cancer treatment, but they also live longer after diagnosis — getting a benefit that offsets their higher health expenses the study says.

10 Apr 2012

Study provides guidelines on how to combine antiangiogenic drugs with nanotherapeutics

Combining two strategies designed to improve the results of cancer treatment - antiangiogenesis drugs and nanomedicines - may only be successful if the smallest nanomedicines are used. A new study from Massachusetts General Hospital (MGH) researchers, appearing in Nature Nanotechnology, finds that normalizing blood vessels within tumors, which improves the delivery of standard chemotherapy drugs, can block the delivery of larger nanotherapy molecules.

10 Apr 2012

More than 60% of breast cancer survivors report post-treatment complications

More than 60 percent of breast cancer survivors report at least one treatment-related complication even six years after their diagnosis, according to a new study led by a researcher from the Perelman School of Medicine at the University of Pennsylvania.

10 Apr 2012

Special issue focuses on costs, benefits and hope inspired by cancer care

A new analysis provides a closer look at how much cancer patients value hope - with important implications for how insurers value treatment, particularly in end-of-life care.

10 Apr 2012

New dietary supplement may arrest, lower rising PSA in men with recurrent prostate cancer

Preliminary findings from an FDA-approved clinical trial indicate that the experimental dietary supplement Prostate Health Cocktail (PHC) may arrest and in some cases lower rising PSA (Prostate Specific Antigen) in men with recurrent prostate cancer.

9 Apr 2012

Delivering chemotherapy drugs with nanobubbles more deadly to cancer cells

Using light-harvesting nanoparticles to convert laser energy into "plasmonic nanobubbles," researchers at Rice University, the University of Texas MD Anderson Cancer Center and Baylor College of Medicine (BCM) are developing new methods to inject drugs and genetic payloads directly into cancer cells.

9 Apr 2012

MD Anderson initiates Phase 1/2 entinostat-lapatinib ditosylate combination study in metastatic breast cancer

Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announced that investigators at The University of Texas MD Anderson Cancer Center Department of Breast Medical Oncology have initiated a phase 1/2 study combining Syndax's lead product entinostat with lapatinib ditosylate (Tykerb) in patients with locally recurrent or distant relapsed metastatic breast cancer previously treated with trastuzumab (Herceptin).

9 Apr 2012

KU researchers receive inventorship credit on NIH-owned Velcade patents

Pillsbury today announced that its clients, the University of Kansas and the University of Kansas Center for Research, Inc., a nonprofit corporation affiliated with KU, prevailed in a closely watched legal battle over cancer drug formulation patents after an arbitration panel ruled in KUCR's favor following years of litigation against the National Institutes of Health.

7 Apr 2012

Research on how cells cope with stress could lead to more effective cancer treatment

Both radiation and many forms of chemotherapy try to kill tumors by causing oxidative stress in cancer cells. New research from USC on a protein that protects cancer and other cells from these stresses could one day help doctors to break down cancer cells' defenses, making them more susceptible to treatment.

7 Apr 2012

TJUH medical oncologist to receive ASCO Humanitarian Award

Edith Mitchell, M.D., FACP, a medical oncologist at Thomas Jefferson University Hospital and Jefferson's Kimmel Cancer Center (KCC) and Clinical Professor of Medicine and Medical Oncology in the Department of Medical Oncology at Jefferson Medical College of Thomas Jefferson University, has been named the 2012 recipient of the American Society of Clinical Oncology (ASCO) Humanitarian Award for her personification of the society's mission and values, and for going above and beyond the call of duty in providing outstanding patient care.

6 Apr 2012

Zalicus' cHTS platform identifies synergistic drug combinations for treatment of cancer

Adenosine A2A and beta-2 adrenergic receptor agonists are highly synergistic and selective novel agents that enhance glucocorticoid activity in B-cell malignancies such as multiple myeloma and, importantly, can synergize in combination with current multiple myeloma treatment regimens such as melphalan, lenalidomide, bortezomib and doxorubicin.

6 Apr 2012

Cancer Treatment News and Research

High intensity focused ultrasound to treat prostate cancer shows initial success

More than one third of patients with invasive cancer are undertreated for their pain

Physical activity reduces depression, enhances QOL during treatment for breast cancer

Longer looks: Diagnosing autism in minutes; Finding new uses for old drugs; Cancer war victories

New image-guided radiotherapy system at DMC Huron Valley-Sinai Hospital

Majority of Michigan oncology practices follow treatment guidelines for common cancers

New supplement outlines prospective surveillance model for breast cancer

Peter Mac doctor receives grant to fight prostate cancer

Spider venom studied as treatment for breast cancer

High cancer treatment costs in the US – are they worth it? Study explores

Study provides guidelines on how to combine antiangiogenic drugs with nanotherapeutics

More than 60% of breast cancer survivors report post-treatment complications

Special issue focuses on costs, benefits and hope inspired by cancer care

New dietary supplement may arrest, lower rising PSA in men with recurrent prostate cancer

Delivering chemotherapy drugs with nanobubbles more deadly to cancer cells

MD Anderson initiates Phase 1/2 entinostat-lapatinib ditosylate combination study in metastatic breast cancer

KU researchers receive inventorship credit on NIH-owned Velcade patents

Research on how cells cope with stress could lead to more effective cancer treatment

TJUH medical oncologist to receive ASCO Humanitarian Award

Zalicus' cHTS platform identifies synergistic drug combinations for treatment of cancer

Cancer Research eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News